SBIR-STTR Award

Development of Tumor Vaccines Using GPI-Linked Molecules
Award last edited on: 12/19/14

Sponsored Program
SBIR
Awarding Agency
NIH : NCI
Total Award Amount
$100,681
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Andrew H Segal

Company Information

Genitrix LLC

1 Emerson Place Unit 9h
Boston, MA 02114
   (617) 742-3954
   eyoung@genitrix.com
   N/A
Location: Single
Congr. District: 08
County: Suffolk

Phase I

Contract Number: 1R43CA074665-01A1
Start Date: 00/00/00    Completed: 00/00/00
Phase I year
1997
Phase I Amount
$84,474


Thesaurus Terms:
glycosylphosphatidylinositol, neoplasm /cancer immunology, neoplasm /cancer vaccine, opsonin, transfection, vaccine development antigen antibody reaction, antigen presentation, antigen presenting cell, cell membrane, chimeric protein, gene targeting, lymphocyte, natural killer cell, neoplasm /cancer immunotherapy laboratory mouse, neoplastic cell. antigen antibody reaction; antigen presentation; antigen presenting cell; cell membrane; chimeric proteins; gene targeting; glycosylphosphatidylinositols; laboratory mouse; lymphocyte; natural killer cells; neoplasm /cancer immunology; neoplasm /cancer immunotherapy; neoplasm /cancer vaccine; neoplastic cell; opsonin; transfection; vaccine development

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
$16,207